Literature DB >> 2248819

Effects of nimodipine on cerebral blood flow and neuropsychological outcome after cardiac surgery.

M Forsman1, B T Olsnes, G Semb, P A Steen.   

Abstract

Thirty-five patients undergoing cardiac surgery requiring cardiopulmonary bypass (CPB) were allocated randomly in a prospective double-blind study to receive either nimodipine 0.5 micrograms kg-1 min-1 or placebo. Cerebral blood flow (CBF) was measured during and immediately after CPB. Neuropsychological tests were performed 6 months after surgery to determine any relationship between ischaemic damage and CBF and administration of nimodipine. There were no differences in CBF between the nimodipine (n = 18) and placebo groups (n = 17). Significant changes in neuropsychological tests were found in six patients tested 6 months after surgery but there were no conclusive signs of ischaemic damage. The nimodipine-treated group performed better in tests of verbal fluency and visual retention, suggesting that some memory functions were preserved better in this group.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2248819     DOI: 10.1093/bja/65.4.514

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

Review 1.  Pharmacologic neuroprotection: the search continues.

Authors:  Hilary P Grocott
Journal:  J Extra Corpor Technol       Date:  2007-12

2.  Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial.

Authors:  Rebecca Y Klinger; Mary Cooter; Tiffany Bisanar; Niccolò Terrando; Miles Berger; Mihai V Podgoreanu; Mark Stafford-Smith; Mark F Newman; Joseph P Mathew
Journal:  Anesthesiology       Date:  2019-06       Impact factor: 7.892

Review 3.  Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders.

Authors:  Dharmendra Kumar Khatri; Amey Kadbhane; Monica Patel; Shweta Nene; Srividya Atmakuri; Saurabh Srivastava; Shashi Bala Singh
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-04-08

Review 4.  Neurological and psychiatric adverse effects of anaesthetics: epidemiology and treatment.

Authors:  J M Klafta; J P Zacny; C J Young
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

Review 5.  Drugs acting on calcium channels: potential treatment for ischaemic stroke.

Authors:  B J Alps
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

6.  Cerebral oxygenation and haemodynamic effects induced by nimodipine in healthy subjects.

Authors:  Daniela Canova; Silvestro Roatta; Giuseppe Micieli; Daniele Bosone
Journal:  Funct Neurol       Date:  2012 Jul-Sep

Review 7.  Drug repositioning for Alzheimer's disease.

Authors:  Anne Corbett; James Pickett; Alistair Burns; Jonathan Corcoran; Stephen B Dunnett; Paul Edison; Jim J Hagan; Clive Holmes; Emma Jones; Cornelius Katona; Ian Kearns; Patrick Kehoe; Amrit Mudher; Anthony Passmore; Nicola Shepherd; Frank Walsh; Clive Ballard
Journal:  Nat Rev Drug Discov       Date:  2012-11       Impact factor: 84.694

Review 8.  Lignocaine: neuro-protective or wishful thinking?

Authors:  Simon J Mitchell; Alan F Merry
Journal:  J Extra Corpor Technol       Date:  2009-03

Review 9.  Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.

Authors:  A N Wadworth; D McTavish
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

Review 10.  Cognitive deficits related to major organ failure: the potential role of neuropsychological testing.

Authors:  M E Farmer
Journal:  Neuropsychol Rev       Date:  1994-06       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.